Back to Search
Start Over
A New Approach to the Management of Anemia in CKD Patients: A Review on Roxadustat.
- Source :
-
Advances in therapy [Adv Ther] 2017 Apr; Vol. 34 (4), pp. 848-853. Date of Electronic Publication: 2017 Mar 13. - Publication Year :
- 2017
-
Abstract
- This article informs the reader of the current information available on a novel therapeutic agent and new class of drug for the treatment of anemia. The data show promising results for alternative erythropoietin-stimulating agents and offers a time line of when Phase III data will be available. The information on this new drug and new drug class will change how nephrologists approach treating anemia within their patients.
- Subjects :
- Glycine administration & dosage
Glycine adverse effects
Glycine therapeutic use
Hematinics administration & dosage
Hematinics adverse effects
Humans
Isoquinolines administration & dosage
Isoquinolines adverse effects
Anemia drug therapy
Anemia etiology
Glycine analogs & derivatives
Hematinics therapeutic use
Isoquinolines therapeutic use
Renal Insufficiency, Chronic complications
Subjects
Details
- Language :
- English
- ISSN :
- 1865-8652
- Volume :
- 34
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- Advances in therapy
- Publication Type :
- Academic Journal
- Accession number :
- 28290095
- Full Text :
- https://doi.org/10.1007/s12325-017-0508-9